Avalo Therapeutics Inc [AVTX]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 44.20% | 44.20% | 47.57% |
| Loss % | -28.55% | -28.55% | 22.26% |
| Duration | 14.0d | 10d | 12.2d |
| Total Pivots Found | 5 |
| Gain/Loss Legs | 4 (2 Gain / 2 Loss) |
| Last Pivot | Bottom @ $12.74 on 2026-06-08 |
| Change since Last Pivot | $1.96 (15.38%) |
Next Pivot Prediction Last: $0.00
| Predicted Next Type | Top |
| Predicted Price (Avg) | $18.37 |
| Predicted Price (Median) | $18.37 |
| Predicted Price Range (~68%) | $12.31 - $24.43 |
| Change to Avg Target | $18.37 (N/A) |
| Predicted Date (Avg) | 2026-06-22 |
| Predicted Date Range (~68%) | 2026-06-09 - 2026-07-04 |
| Basis | Based on 2 historical gains (Avg: 44.20%, Median: 44.20%, StdDev: 47.57%) and duration (Avg: 14.0 days, StdDev: 12.2 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Avalo Therapeutics Inc declines -4.55%.
Avalo Therapeutics Inc (AVTX) stock price faced a major setback on Thursday after the stock fell $-0.700 (-4.55%) from the previous session on extraordinarily high volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 1.91% rise. With 6.42M shares traded, volume yesterday reached $94.34M. This was 5.25M shares more than the prior day. Compared to the 10-day average of 1.27M shares, volume was more than the average.
Avalo Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above the short-term average yet below the long-term average, with the short-term average still below the long-term average; signals are mixed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-3.3%), medium- (-3.3%), and long-term (-3.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Avalo Therapeutics Inc Support & Resistance Levels
The stock is trading above the closest support level at $14.40. approximately $0.300 (2.04%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s114.4 -
Avalo Therapeutics Inc Evaluation
- Short score: 0.41
- Medium score: -0.44
- Long score: -0.42